Quinoline

Quinoline

SCHEMBL4485979

O=C(O)C(F)F.c1ccc2ncccc2c1

nearest known ligand 0.63

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.63
PABPC1 P11940 1/20 0.45
KDM4E B2RXH2 3/20 0.45
NPSR1 Q6W5P4 2/20 0.45
RXFP1 Q9HBX9 2/20 0.45
PRNP P04156 1/20 0.45
MAPK10 P53779 1/20 0.45
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
NPC1 O15118 2/20 0.44
POLB P06746 2/20 0.44
MAPT P10636 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.43
LMNA P02545 1/20 0.43
MGAM O43451 2/20 0.43
CYP3A4 P08684 2/20 0.43
CASP1 P29466 1/20 0.43
CASP7 P55210 1/20 0.43
AKR1C3 P42330 1/20 0.43
AKR1C2 P52895 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Quinoline SCHEMBL28970061 0.86 ALDH1A1 (0.71) ALDH1A1PABPC1KDM4EMEN1KMT2A
Quinoline SCHEMBL372690 0.86 ALDH1A1 (0.77) ALDH1A1PABPC1KDM4EMEN1KMT2A
Quinoline SCHEMBL5283313 0.86 ALDH1A1 (0.77) ALDH1A1PABPC1KDM4EMEN1KMT2A
Quinoline SCHEMBL5874493 0.86 ALDH1A1 (0.77) ALDH1A1PABPC1KDM4EMEN1KMT2A
Cadaverine Tartrate SCHEMBL5874249 0.85 ALDH1A1 (0.63) ALDH1A1PABPC1KDM4ENPSR1RXFP1
Quinoline SCHEMBL5874640 0.85 ALDH1A1 (0.63) ALDH1A1PABPC1KDM4ENPSR1RXFP1
Cadaverine Tartrate SCHEMBL5874237 0.85 ALDH1A1 (0.63) ALDH1A1PABPC1KDM4ENPSR1RXFP1
Cadaverine Tartrate SCHEMBL28081412 0.85 ALDH1A1 (0.63) ALDH1A1PABPC1KDM4ENPSR1RXFP1
Quinoline SCHEMBL5272119 0.84 ALDH1A1 (0.74) ALDH1A1PABPC1KDM4EMEN1KMT2A
Quinoline SCHEMBL2201840 0.84 ALDH1A1 (0.74) ALDH1A1PABPC1KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7511065-B2 Mixed lineage kinase modulators ELI LILLY AND COMPANY (US) 2009-03-31 US disclosed
US-20080113977-A1 Mixed Lineage Kinase Modulators ELI LILLY AND COMPANY 2008-05-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080113977-A1 Mixed Lineage Kinase Modulators MYLK2, CSNK1G2, CSNK1A1 ALDH1A1 3779/4885PABPC1 1949/4885KDM4E 2001/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.